TIA’s vision is to enable and accelerate the translation of research discoveries along the development pipeline by ensuring that excellent translational research services are accessible by the Australian translational research community. To make this vision a reality, we have partnered with leading national research infrastructure facilities across three capabilities - Small Molecules, Biologics and Cell and Gene Therapies, to deliver world-class research infrastructure across Australia.
These capabilities represent
product classes that account for the majority of products currently in clinical development.
For a list of specific facilities, refer to the table below or visit the Pipeline Navigator.
TIA-supported national research infrastructure